Portfolio (Quarterly)
Guide ↗
Stonepine Capital Management, LLC
· CIK 0001440771| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | — | VERASTEM INC | — | 3,302,300.0 | $17.5M | 7.01% | +570K | +20.9% | $5.30 | — |
| 2 | — | TENAX THERAPEUTICS INC | — | 975,200.0 | $15.6M | 6.24% | +963K | +8106.0% | $15.99 | — |
| 3 | EOLS | EVOLUS INC | Healthcare | 1,759,091.0 | $7.2M | 2.90% | +128K | +7.8% | $4.11 | +50.4% |
| 4 | CAMP | CAMP4 THERAPEUTICS CORP | Healthcare | 1,389,622.0 | $6.1M | 2.45% | +1.2M | +507.1% | $4.41 | -7.8% |
| 5 | — | ABEONA THERAPEUTICS INC | — | 746,587.0 | $3.3M | 1.34% | +37K | +5.2% | $4.48 | — |
| 6 | ANTX | AN2 THERAPEUTICS INC | Healthcare | 713,845.0 | $2.4M | 0.98% | +86K | +13.7% | $3.42 | +45.6% |
| 7 | — | CURIS INC | — | 3,726,406.0 | $2.0M | 0.82% | +3.7M | +6178.8% | $0.55 | — |
| 8 | TELA | TELA BIO INC | Healthcare | 2,617,252.0 | $1.6M | 0.65% | +265K | +11.3% | $0.62 | +32.9% |
| 9 | — | ADICET BIO INC | — | 221,955.0 | $1.5M | 0.60% | +2K | +0.9% | $6.81 | — |
| 10 | HRTX | HERON THERAPEUTICS INC | Healthcare | 1,402,191.0 | $1.1M | 0.45% | +164K | +13.3% | $0.80 | +9.2% |
| 11 | LUNG | PULMONX CORP | Healthcare | 768,288.0 | $991K | 0.40% | +282K | +58.0% | $1.29 | +19.8% |
| 12 | INAB | IN8BIO INC | Healthcare | 663,412.0 | $982K | 0.39% | +499K | +302.3% | $1.48 | +14.5% |
| 13 | BIOA | BIOAGE LABS INC | Healthcare | 50,000.0 | $874K | 0.35% | +5K | +11.1% | $17.49 | -7.3% |
| 14 | MXCT | MAXCYTE INC | Healthcare | 1,004,673.0 | $706K | 0.28% | +536K | +114.2% | $0.70 | +41.2% |
| 15 | CDXS | CODEXIS INC | Healthcare | 417,994.0 | $681K | 0.27% | +162K | +63.2% | $1.63 | +58.6% |
| 16 | — | PASITHEA THERAPEUTICS CORP | — | 831,301.0 | $617K | 0.25% | +556K | +202.2% | $0.74 | — |
| 17 | CNSP | CNS PHARMACEUTICALS INC | Healthcare | 61,000.0 | $146K | 0.06% | +12K | +24.9% | $2.39 | +127.6% |
| 18 | PCSA | PROCESSA PHARMACEUTICALS INC | Healthcare | 55,000.0 | $139K | 0.06% | +43K | +346.3% | $2.52 | +0.8% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%